astrazeneca Archives

Absci and AstraZeneca forge AI partnership to discover cancer treatments

Absci, a frontrunner in generative AI antibody discovery, has partnered with biopharmaceutical giant AstraZeneca to leverage AI in the quest for a novel cancer treatment.

This collaboration will capitalise on Absci's Integrated Drug Creation platform—seamlessly integrating with AstraZeneca's expertise in oncology, aiming to expedite the discovery of a potentially game-changing cancer therapy.

Under the agreement, Absci will deploy its pioneering generative AI...

4 December 2023 | Applications

NVIDIA launches UK supercomputer to search for healthcare solutions

Nvidia’s ‘Cambridge-1’ is now operational and utilising AI and simulation to advance research in healthcare.

The UK’s most powerful supercomputer and among the world’s top fifty, Cambridge-1 was announced by the technology company in October last year and cost $100 million (£72m) to build.

Its first projects with AstraZeneca, GSK, Guy’s and St Thomas’ NHS Foundation Trust, King’s College London, and Oxford Nanopore Technologies include developing a...

12 July 2021 | Healthcare

GTC 2020: Using AI to help put COVID-19 in the rear-view mirror

This year’s GTC is Nvidia’s biggest event yet, but – like the rest of the world – it’s had to adapt to the unusual circumstances we all find ourselves in. Huang swapped his usual big stage for nine clips with such exotic backdrops as his kitchen.

AI is helping with COVID-19 research around the world and much of it is being powered by NVIDIA GPUs. It’s a daunting task, new drugs often cost over $2.5 billion in research and development — doubling every nine years —...